Shares of Gritstone bio Inc. (GRTSQ) have been struggling lately and have lost 87.3% over the past four weeks. However, a ...

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has announced the appointment of Matthew Peterson, Ph.D., as Senior Clinical ...

Bluebird Bio ( (BLUE) ) has issued an announcement. At bluebird bio, Inc.’s 2024 Annual Meeting, key decisions included increasing the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PHILADELPHIA--(BUSINESS WIRE)--Tolerance Bio, Inc., a biopharmaceutical company pioneering a novel approach to increasing healthspan by preserving, restoring, and manipulating the function of the ...

30, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators ...

Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer’s disease ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Telesis Bio, Inc. (TBIO) on Thursday reported a loss of $6.6 million in its third quarter. On a per-share basis, the San Diego-based company said it had a loss of ...

Adicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was ...